Vitamin D, 25-Hydroxy
Ordering Recommendation
Preferred test to diagnose vitamin D insufficiency and monitor response to therapy. Testing is recommended only for patients at risk for vitamin D insufficiency.
New York DOH Approval Status
Specimen Required
Serum separator tube.
Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.3 mL)
Refrigerated.
EDTA plasma, tissue or urine. Grossly hemolyzed or lipemic specimens.
After separation from cells: Ambient: 72 hours; Refrigerated: 1 week; Frozen: 6 months
Methodology
Quantitative Chemiluminescent Immunoassay
Performed
Sun-Sat
Reported
Within 24 hours
Reference Interval
0-17 years |
|
---|---|
Deficiency | Less than 20 ng/mL |
Optimum level | Greater than or equal to 20 ng/mL* |
*(Wagner CL et al. Pediatrics 2008; 122: 1142-52.) |
18 years and older | |
---|---|
Deficiency | Less than 20 ng/mL |
Insufficiency | 20-29 ng/mL |
Optimum Level | 30-80 ng/mL |
Possible Toxicity | Greater than 150 ng/mL |
Interpretive Data
This assay accurately quantifies the sum of vitamin D3, 25-Hydroxy and vitamin D2, 25-Hydroxy.
FDA
Note
Hotline History
CPT Codes
82306
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
0080379 | Vitamin D 25 OH | 62292-8 |
Aliases
- D, 25-Hydroxy, Vitamin
- Ergocalciferol
- Vit D
- vitamin D